Select the right site in Latin America to accelerate your clinical research data collection

Latin America: Speed and Reliability in Clinical Research

Latin America is a thriving and varied region that presents a multitude of possibilities for clinical research. The key to success lies in finding a research site that delivers results you can trust, and fast. So, why wait any longer to gather the critical data you need to advance your project? Act now and seize the opportunity to leverage the expertise and resources available in Latin America. Don't miss out on the chance to accelerate your research and achieve your goals.

Site Search & Selection Service

  • We will work with you to understand your clinical plans and propose the best country(ies) for your study. Additionally, we will develop a regulatory strategy for your study in Latin America.

  • We will create and send an email to our research network to describe your study and ask if they are interested in participating.

  • We will share our CDA/NDA with potential sites and investigators who have not yet signed it and help them execute it.

  • We will provide potential sites with your study synopsis and site feasibility questionnaire to complete.

  • You will receive a set of site feasibility questionnaires to help identify potential study sites.

  • We will coordinate and facilitate virtual meetings between you and the candidate investigators and heads of research at the potential sites.

  • We can help you with your flight, hotel, and ground transportation. You can also visit the research sites, tour their facilities, and meet the candidate investigators and their research staff. A bilingual member of the bioaccess® team will accompany you throughout your visit.

  • You now have all the necessary information to select sites/investigators and plan the timeline and budget for your study in Latin America.

Cost & Deliverable

We guarantee that with bioaccess® you will find a suitable clinical research site for your Medtech study in Latin America.

Deliverable: Up to two (s) pre-study qualification visit (PSV) forms of potential research sites and investigators willing and able to lead your study (the “Deliverable").

Fee: $25,500

Payment Terms: 50% of the fee will be due upon signature of our master services agreement (MSA), and the remaining 50% will be due upon your receipt of the Deliverable. We will invoice each additional PSV form at $9,300 each.

Travel Expense Reimbursement: The client agrees to reimburse bioaccess™ for all reasonable travel expenses incurred by two (2) bioaccess® representatives in performing services under this proposal. Such travel expenses include, but are not limited to, airfare, ground transportation, hotel accommodations, and meals. bioaccess™ shall submit to the client, monthly or as otherwise agreed upon, itemized receipts and documentation for all travel-related expenses. The client shall review and approve the expenses, which approval shall not be unreasonably withheld, and shall reimburse bioaccess™ within thirty (30) days of receipt of such documentation.

General & Administrative Overhead Fee: bioaccess® will add a 20% surcharge for travel expenses. This includes international wire transfer bank fees, currency exchange fluctuations, and processing payments to third parties such as sites, translators, airlines, hotels, and ground transportation companies. When we travel, a third party refers to anyone we pay on behalf of a sponsor/client, including airlines, hotels, restaurants, ground transportation companies, and taxi services. Every time we travel to a country in Latin America, we encounter currency exchange fluctuations, international debit or credit card fees, ATM cash withdrawal commission fees, and the substantial profit margins that banks make from currency exchange (the spread). In Latin America, many expenses must be paid in cash. When we travel with a sponsor/client, we must withdraw money from ATMs (incurring a commission fee and spread) to cover cash expenses, such as taxi fares, cash-only restaurants, tips, or as a contingency if a bioaccess® US debit or credit card is declined for international transactions flagged as potentially fraudulent by the bank.